Australia-based 4DMedical, the leader in software-based respiratory imaging technology, has announced $100+ million (AU$...
AusBiotech welcomes the Australian Government's announcement, made by the Minister for Trade and Tourism, Senator the Do...
Australia-based AdAlta Limited, developer of next generation cell and protein therapeutic products, and its cellular imm...
The Australian government is investing $10.1 million to support the next generation of health and medical researche...
Swiss firm Santhera Pharmaceuticals has signed an exclusive licensing agreement with Nxera Pharma UK for the development...
Avance Clinical, a full-service Australia headquartered contract research organisation (CRO) focused on accelerating cli...
The World Health Organization (WHO) has formally recognised the regulatory authorities for medical products of Australia...
AeviceMD Monitoring System, a non-invasive wearable respiratory monitoring solution developed by Singapore-based Aevice ...
Researchers in Australia have developed a new antimalarial drug candidate designed to address the growing challenge of d...
Australian startup Ferronova has raised a further $6 million to progress the commercialisation of a novel nano...
Australian biotechnology pioneer Vaxxas Pty Ltd, has been granted a licence by the Therapeutic Goods Administration...
Australia's Monash University is launching Victoria’s most advanced, research-dedicated Magnetic Resonance Im...
Australia-based Immutep Limited and Dr. Reddy’s Laboratories, based in India, have announced that their ...
Australia’s onshore vaccine manufacturing capabilities took a leap forward as Mark Butler MP, Minister for Health,...
Max Healthcare, one of the largest private sector healthcare services companies in India, and Australia's Monash Univers...
SAI Parenterals Limited (SPL), an India-based pharmaceutical formulation company, has announced the acquisition of a 74....
It has been over a year since you took on the role of CEO at AusBiotech. What have been your key priorities so far, and ...
Australia's Imugene has entered a strategic co-development collaboration with Chinese startup JW Therapeutics to evaluat...
